University College, London
Clinical trials sponsored by University College, London, explained in plain language.
-
Engineered immune cells take aim at tough blood cancers
Disease control OngoingThis early-stage trial is testing a personalized cell therapy for adults with certain advanced or relapsed blood cancers that have not responded to standard treatments. Doctors collect a patient's own immune cells, genetically modify them in a lab to better target cancer cells, a…
Phase: PHASE1 • Sponsor: University College, London • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New surgery aims to cure prostate cancer without side effects
Disease control OngoingThis study is testing a new surgical method for prostate cancer that aims to improve patients' quality of life. It compares a new technique called NeuroSAFE, which checks for leftover cancer during surgery, against the standard surgical approach. The goal is to see if the new met…
Phase: NA • Sponsor: University College, London • Aim: Disease control
Last updated Mar 11, 2026 14:53 UTC
-
MRI breakthrough could replace risky kidney biopsies
Diagnosis OngoingThis study is testing whether new types of MRI scans can tell the difference between aggressive and non-aggressive kidney tumors before surgery. Currently, doctors often need to perform invasive biopsies to determine tumor type, which can miss important cancer cells. The research…
Phase: NA • Sponsor: University College, London • Aim: Diagnosis
Last updated Apr 01, 2026 14:41 UTC
-
Daily antibiotic tested to shield leukemia kids from dangerous infections
Prevention OngoingThis trial is testing whether giving children with acute lymphoblastic leukemia (ALL) a daily antibiotic called ciprofloxacin during their initial treatment can prevent serious bacterial infections. The study involves over 300 children aged 1-17 in the UK who are receiving standa…
Phase: NA • Sponsor: University College, London • Aim: Prevention
Last updated Apr 01, 2026 23:11 UTC